LabMD, Inc. CEO Michael J. Daugherty continues to doggedly defend LabMD against an action brought by the Federal Trade Commission (FTC) against LabMD based on Section 5 of the FTC Act. He now has an opportunity to prove himself the “good guy” following last week’s decision by Chief Administrative Law Judge D. Michael Chappell granting
Section 5
Risky (Health Care) Business: Disclosure of FTC Data Security Enforcement Potential to Investors and Other Third Parties
By Elizabeth Litten on
Posted in Privacy & Security
Readers of this blog know that we have been tracking the FTC’s recent data security enforcement activities with a particular focus on the FTC v. LabMD case. As reported by Cause of Action, a nonprofit organization involved in the defense of LabMD, the LabMD trial was put on hold on May 30, 2014 until June…